• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
orodispersible_dosage_forms
orodispersible_dosage_forms

... metabolism and can be an advantage in drugs that undergo a great deal of hepatic metabolism. However, if the amount of swallowed drug varies, there is the potential for inconsistent bioavailability. While the claimed increase in bioavailability is debatable, it is clear that the major advantage of t ...
Detox regimens for party drugs
Detox regimens for party drugs

... unable to stop for more than 2 days at a time or else he would experience withdrawal symptoms (described similarly to his 2011 episode). Crucially for the first time, in by now his 7 years of continual GHB use, he was primarily experiencing negative effects whenever he used. The major symptoms inclu ...
Pharmacodynamic and pharmacokinetic drug interactions
Pharmacodynamic and pharmacokinetic drug interactions

... As a drug may be involved in several clinically important mechanisms, all mechanisms found for the drug in the literature review were summarised. To investigate if reported response (based on reports in VigiBase) corresponded to the expected outcome of verified drug interactions, top reported ADR te ...
Adverse Drug Reaction–Related Hospitalizations Among
Adverse Drug Reaction–Related Hospitalizations Among

... Identifying ADRs retrospectively using administrative hospital data is likely to underestimate the prevalence of ADR-related hospitalizations, as necessary data may be missing or inaccurately recorded.5, 6, 18 Although study design has been shown to affect the estimated prevalence of ADRs, results a ...
Pharmacology Review #1 - Madison County Emergency Medical
Pharmacology Review #1 - Madison County Emergency Medical

... Bledsoe et al., Paramedic Care Principles & Practice Volume 1: Introduction © 2006 by Pearson Education, Inc. Upper Saddle River, NJ ...
Medicare Part D and Prescription Drug Utilization
Medicare Part D and Prescription Drug Utilization

... This paper uses the substantial increase in prescription drug coverage for the elderly that resulted from the adoption of Part D to generate new estimates the impact of prescription drug insurance coverage on drug utilization. The analysis uses detailed data on a strongly balanced panel of those 65 ...
New Drugs from Old
New Drugs from Old

... • PI uses ‘lifecycle management’ to minimise loss & maximise returns from such products, including: ...
Evaluation for Zero-order Controlled Release Preparations of
Evaluation for Zero-order Controlled Release Preparations of

... Generic drugs are the same as the brand-name drug in distribution, metabolism, excretion after absorption, but diŠerent in dissolution proˆles. For speciˆc dosage forms such as controlled-release preparations, we may need to establish new evaluation criteria and test methods. These should consider t ...
Biopharmaceutics / lecture 12 Dr. Aymen Bash Intravenous Infusion
Biopharmaceutics / lecture 12 Dr. Aymen Bash Intravenous Infusion

... drug equilibrium is not immediate. If a loading dose is given too rapidly, the drug may initially give excessively high concentrations in the plasma (central compartment), which then decreases as drug equilibrium is reached. It is not possible to maintain an instantaneous, stable steady-state blood ...
Chapter 11 lesson 3 - ROP Pharmacology for Health Care
Chapter 11 lesson 3 - ROP Pharmacology for Health Care

... on the label tells the pharmacist that this stock bottle is already open and to us it to fill the next patient's prescription for digoxin. Digoxin's well-known trade name is Lanoxin. Understanding Pharmacology for Health Professionals, 5th Ed. Susan M. Turley ...
Pharmacy history
Pharmacy history

... penicillin, which had lain dormant in Fleming's laboratory for 10 years. The technology, scientific knowledge and need were present all at once and post-world war II pharmaceutical industry began producing drugs that were much more powerful and specific than those available previously. ...
Straight Facts About Drugs and Drug Abuse
Straight Facts About Drugs and Drug Abuse

... highway crashes, and ever-growing costs of law enforcement and health care, are a major social concern. The widespread availability and use of drugs means that drug-related problems will impact all Canadians in one way or another. As a result, there is a need for accurate information about different ...
FORMULATION AND EVALUATION OF DICLOFANAC POTASSIUM ETHOSOMES  Research Article  VIJAYAKUMAR M.R., ABDUL HASAN SATHALI A , ARUN K. 
FORMULATION AND EVALUATION OF DICLOFANAC POTASSIUM ETHOSOMES  Research Article  VIJAYAKUMAR M.R., ABDUL HASAN SATHALI A , ARUN K. 

... collected  and  dispersed  in  the  carbopol  980(2%)  gel  base  with  gentle  stirring  to  obtain  the  total  drug  equivalent  to  1%w/w  of  diclofenac potassium.  In vivo anti inflammatory activity 13  The  anti  inflammatory  activity  was  carried  out  by  carrageenan  induced  paw  oedema ...
Drug Interactions with St. John`s Wort
Drug Interactions with St. John`s Wort

... administration are required to produce the maximum effect on enzyme induction and a similar time to revert back to baseline following discontinuation of SJW. SJW, in a manner similar to rifampin, binds to the pregnane X receptor, resulting in stimulation of the genes that produce several cytochrome ...
New Psychoactive Substances-High index of suspicion needed in
New Psychoactive Substances-High index of suspicion needed in

... effects such as agitation, raised blood pressure, tachycardia, dilated pupils, clonus and seizures as seen with the synthetic cathinones. Hallucinations due to 5HT2A agonism however are more prominent in this group of compounds. Biochemical abnormalities reported include elevated creatine kinase, d ...
Neurotranslation Program
Neurotranslation Program

... The Pharmaceutical industry is Under Challenge • The industry is investing more than three times as much as a decade a ago to produce less than half as many new products • Phase II timelines have nearly doubled; Phase III timelines have increased by ~50% • Number of NMEs per $1B spent is a factor 50 ...
O - Yale University
O - Yale University

... patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgement. If physicians use a product for an indication not in the approved labeling, they have the responsibility to be well informed about the product, to base its use on firm ...
hollow microsphere: a review
hollow microsphere: a review

... residence time of dosage forms in the upper gastrointestinal tract, a prominent site for absorption of many drugs, will lead to lower bioavailability. Efforts to improve oral drug bioavailability have grown in parallel with the pharmaceutical industry. As the number and chemical diversity of drugs h ...
BCBST Preferred Drug List
BCBST Preferred Drug List

... have been reviewed by BlueCross BlueShield of Tennessee. Please refer to this formulary guide for information about the availability of frequently prescribed medications covered by your plan. This guide is not meant to be comprehensive but to provide a list of the most commonly prescribed drugs. Thi ...
Title of presentation - Delaware Valley Drug Metabolism Discussion
Title of presentation - Delaware Valley Drug Metabolism Discussion

... are the major transporters that mediate DDI and all NME should routinely be evaluated …. as substrates for these transporters…. Those voting no agreed the proposed transporters are reasonable, but cited the absence of appropriate tools to conduct the studies. "Throwing this out there to the pharmace ...
Hospital brochure - LMA™ Better by design
Hospital brochure - LMA™ Better by design

... At the point of drug delivery, LMA MAD Nasal™ eliminates the risk of needlestick injuries. There are a number of benefits associated with needle-free drug delivery: A  ddresses concerns over blood-borne pathogens A  broader scope of healthcare workers can deliver drugs intranasally without having ...
DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHOD FOR
DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHOD FOR

... the drugs were soluble in 0.1N HCl. Preparation of standard stock solution Accurately about 25 mg of each drug was weighed and dissolved in 10 ml 0.1 HCl and sonicated for 15 minutes. The volume was made up to 25 ml with 0.1 N HCl to obtain standard stock solution (1000 μg/ml). From this, 2.5 ml sol ...
clinical pharmacokinetics-4
clinical pharmacokinetics-4

... This is a function of the rate of absorption & the rate of elimination. o If the rate of absorption is > the rate of elimination, the conc. will increase. o If the rate of absorption is < the rate of elimination, the conc. will decrease. o If the rate of absorption is = the rate of elimination, the ...
Clinically relevant drug interactions with antiepileptic drugs
Clinically relevant drug interactions with antiepileptic drugs

... Institute of Neurology IRCCS C. Mondino Foundation, Pavia, and Clinical Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy ...
Pharmacokinetics - PHARMACEUTICAL REVIEW
Pharmacokinetics - PHARMACEUTICAL REVIEW

... This is a function of the rate of absorption & the rate of elimination. o If the rate of absorption is > the rate of elimination, the conc. will increase. o If the rate of absorption is < the rate of elimination, the conc. will decrease. o If the rate of absorption is = the rate of elimination, the ...
< 1 ... 32 33 34 35 36 37 38 39 40 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report